Journal ArticleOPEN ACCESS

Nebulized amphotericin B combined with intravenous amphotericin B in rats with severe invasive pulmonary aspergillosis

Antimicrobial Agents and Chemotherapy (2006) 50(5) 1852-1854
DOI: 10.1128/AAC.50.5.1852-1854.2006
11Citations
Citations of this article
17Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Nebulized amphotericin B (AMB) combined with intravenous AMB was studied in persistently leukopenic rats with invasive pulmonary aspergillosis. Pulmonary concentrations of AMB after aerosol treatment were substantially higher than after intravenous liposomal AMB. Nebulized liposomal AMB in addition to intravenous AMB resulted in significantly prolonged survival compared to controls. Copyright © 2006, American Society for Microbiology. All Rights Reserved.

Cite

CITATION STYLE

APA

Ruijgrok, E. J., Fens, M. H. A. M., Bakker-Woudenberg, I. A. J. M., Van Etten, E. W. M., & Vulto, A. G. (2006). Nebulized amphotericin B combined with intravenous amphotericin B in rats with severe invasive pulmonary aspergillosis. Antimicrobial Agents and Chemotherapy, 50(5), 1852–1854. https://doi.org/10.1128/AAC.50.5.1852-1854.2006

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free